← All diseases
Cancer
Bile duct cancer
Would you like to receive a message when there is new research on cholangiocarcinoma? This is possible with an account. Create a free account or log in.
Automatically tracked from PubMed and ClinicalTrials.gov, newest on top. Nothing ever disappears here: what you keep in your favorites remains findable. · RSS feed of this disease · only the strongest evidence
Read in plain language what each study is about? With Premium, a one-sentence summary explaining what was studied appears above each publication — and you'll be notified as soon as new research on Cholangiocarcinoma is published. View what Premium costs.
Publications and studies (2068)
- The Effect of Iodine-125 Radioactive Particle Stent with Doxorubicin-loaded Nano-tetrahedrons Combined with Transarterial Chemoembolization on Survival and Prognosis of Patients with Cholangiocarcinoma. (2022/08/31) ♡
- Characterization of the cholangiocarcinoma drug pemigatinib against FGFR gatekeeper mutants. (2022/08/22) ♡
- Laboratory or animal researchiNo research in humans yet. Promising in a test tube or in mice unfortunately means nothing for patients. Exploring in vitro anti-proliferative and anti-inflammatory activities of Prasachandaeng remedy, and its bioactive compounds. (2022/08/11) ♡
- Associations between ultrasound screening findings and cholangiocarcinoma diagnosis in an at-risk population. (2022/08/06) ♡
- Commentary or editorialiAn expert's opinion or commentary, not new research. Surveillance for cholangiocarcinoma in patients with primary sclerosing cholangitis: Can we be more proactive? (2022/08/04) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. An Intrahepatic Cholangiocarcinoma with Focal Rhabdoid Features and SMARCA4-Deficiency. (2022/08/01) ♡
- β-Catenin Sustains and Is Required for YES-associated Protein Oncogenic Activity in Cholangiocarcinoma. (2022/08/01) ♡
- NOTCH-YAP1/TEAD-DNMT1 Axis Drives Hepatocyte Reprogramming Into Intrahepatic Cholangiocarcinoma. (2022/08/01) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Outcome of liver cancer patients with SARS-CoV-2 infection: An International, Multicentre, Cohort Study. (2022/08/01) ♡
- Tumor budding may be a promising prognostic indicator in intrahepatic cholangiocarcinoma: A multicenter retrospective study. (2022/07/30) ♡
- In Silico Target Identification of Galangin, as an Herbal Flavonoid against Cholangiocarcinoma. (2022/07/21) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Hyperphosphatemic Tumoral Calcinosis With Pemigatinib Use. (2022/07/16) ♡
- The Chemopreventive Role of β-Elemene in Cholangiocarcinoma by Restoring PCDH9 Expression. (2022/07/12) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. MED12-related Hardikar syndrome: Two additional cases and novel phenotypic features. (2022/07/01) ♡
- Multimodule characterization of immune subgroups in intrahepatic cholangiocarcinoma reveals distinct therapeutic vulnerabilities. (2022/07/01) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Primary Biliary Tuberculosis Masquerading Cholangiocarcinoma in (18)F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography. (2022/07/01) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. [Experience with digital peroral cholangioscopy using SpyGlass DS in different reference centers in gastroenterology and digestive endoscopy in Colombia: Case series]. (2022/07/01) ♡
- Prevalence of Suspected Cholangiocarcinoma Based on Ultrasonography Screening and its Associated Factors in Northeastern Thailand. (2022/07/01) ♡
- Risk of Cancer in Paediatric onset Inflammatory Bowel Diseases: A Nation-wide Study From the epi-IIRN. (2022/06/24) ♡
- Improved Survival and Quality of Life Through an Integrative, Multidisciplinary Oncological Approach: Pathophysiological Analysis of Four Clinical Cancer Cases and Review of the Literature. (2022/06/16) ♡
- Systemic Treatments with Tyrosine Kinase Inhibitor and Platinum-Based Chemotherapy in Patients with Unresectable or Metastatic Hepatocholangiocarcinoma. (2022/06/14) ♡
- Crowberry inhibits cell proliferation and migration through a molecular mechanism that includes inhibition of DEK and Akt signaling in cholangiocarcinoma. (2022/06/13) ♡
- Validation study of postoperative liver failure and mortality risk scores after liver resection for perihilar cholangiocarcinoma. (2022/06/01) ♡
- Commentary or editorialiAn expert's opinion or commentary, not new research. Editorial on "Short- and long-term outcomes after hemihepatectomy for perihilar cholangiocarcinoma: does left or right side matter?". (2022/06/01) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Severe side effects caused by parenteral nutrition therapy with fat emulsion (10%)/amino acids (15)/glucose (20%) injection: 2 case reports. (2022/06/01) ♡
- Polymethoxylated flavone sudachitin is a safe anticancer adjuvant that targets glycolysis in cancer-associated fibroblasts. (2022/05/31) ♡
- Laboratory or animal researchiNo research in humans yet. Promising in a test tube or in mice unfortunately means nothing for patients. FXR expression in rats of hilar cholangiocarcinoma. (2022/05/24) ♡
- Circular RNA circEIF3C promotes intrahepatic cholangiocarcinoma progression and immune evasion via the miR-34a-5p/B7-H4 axis. (2022/05/19) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. IgG4-Related Sclerosing Cholangitis with Cholecystitis Mimicking Cholangiocarcinoma: A Case Report. (2022/05/01) ♡
- Lower Incidence of Hepatobiliary Cancer in Helicobacter pylori-Infected Persons: A Cohort Study of 53.633 Persons. (2022/05/01) ♡
- Systematic reviewiAll research on one question is searched according to fixed rules and compared side by side, so that no studies with poor outcomes are missed. Wogonin and its analogs for the prevention and treatment of cancer: A systematic review. (2022/05/01) ♡
- A New Prognostic Model Covering All Stages of Intrahepatic Cholangiocarcinoma. (2022/04/28) ♡
- PD-1+ T-Cells Correlate with Nerve Fiber Density as a Prognostic Biomarker in Patients with Resected Perihilar Cholangiocarcinoma. (2022/04/27) ♡
- Incidence and Patterns of Liver Cancers in Sri Lanka from 2001 to 2010: Analysis of National Cancer Registry Data. (2022/04/25) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. The role of tumor-infiltrating lymphocytes in cholangiocarcinoma. (2022/04/07) ♡
- Ethnopharmacological nexus between the traditional Thai medicine theory and biologically based cancer treatment. (2022/04/06) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Cutting edge issues in juvenile sclerosing cholangitis. (2022/04/01) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Hepatic tuberculosis masquerading as malignancy. (2022/04/01) ♡
- Addressing unmet needs for people with cancer cachexia: recommendations from a multistakeholder workshop. (2022/04/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Novel biomarkers and the future of targeted therapies in cholangiocarcinoma: a narrative review. (2022/04/01) ♡
- Inhibition of ALDH2 by disulfiram leads to synthetic lethality via ROS strikes twice in ARID1A-deficient cholangiocarcinoma. (2022/03/16) ♡
- ACOT12-mediated acetyl-CoA hydrolysis suppresses intrahepatic cholangiocarcinoma metastasis by inhibiting epithelial-mesenchymal transition. (2022/03/14) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Molecular Mechanisms Linking Risk Factors to Cholangiocarcinoma Development. (2022/03/11) ♡
- Preoperative Assessment of Skeletal Muscle Mass and Muscle Quality Using Computed Tomography: Incidence of Sarcopenia in Patients with Intrahepatic Cholangiocarcinoma Selected for Liver Resection. (2022/03/10) ♡
- Rapid assessment of Opisthorchis viverrini IgG antibody in serum: A potential diagnostic biomarker to predict risk of cholangiocarcinoma in regions endemic for opisthorchiasis. (2022/03/01) ♡
- Added-value of ancillary imaging features for differentiating hepatocellular carcinoma from intrahepatic mass-forming cholangiocarcinoma on Gd-BOPTA-enhanced MRI in LI-RADS M. (2022/03/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Advances in pharmacotherapy for cholangiocarcinoma: from conventional therapies to targeted drugs. (2022/03/01) ♡
- Arterial enhancement pattern predicts survival in patients with resectable and unresectable intrahepatic cholangiocarcinoma. (2022/03/01) ♡
- Population dynamics and diversity of trematode infections in Bithynia siamensis goniomphalos in an irrigated area in northeast Thailand. (2022/03/01) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. First Report of a Paediatric Collision Tumour in the Liver Recognised After Liver Transplantation: Blissful Ignorance Has Benefits! (2022/03/01) ♡
codex.care does not provide medical advice. Always discuss symptoms, medication, and treatment choices with your own healthcare provider.